Navinci’s Multiplex isPLA, Omni, Featured in Nature Communications Publication from the ASTEROID Phase 1 Clinical Trial

Navinci is pleased to highlight the publication of a new study in Nature Communications reporting findings from the ASTEROID Phase 1 clinical trial.